In mice, invading glioblastoma cells hijacked cerebral blood vessels early in the disease and damaged the blood-brain barrier. The NINDS-funded authors, writing in Nature Communications, say this could let therapies reach the cells sooner than previously thought possible.
Section archive
Page 23 of 86
Miscellaneous
Other health and consumer news.
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Miscellaneous
Langston V2 Dual Lumen Catheters (Models 5540 and 5550) by Vascular Solutions: Class I Recall - Inner Catheter May Separate During Use and Cause Injury
Vascular Solutions recalled Langston V2 Dual Lumen Catheters after reports that the inner catheter separated from the hub during use, which may require a procedure to retrieve the piece. No patient injuries were reported, but FDA says use could cause serious harm or death.
Miscellaneous
NIH funds next step of cutting edge research into Alzheimer's disease genome
NIH awarded grants expected to total $24 million over four years to eight academic medical centers to analyze genome sequence data from the Alzheimer's Disease Sequencing Project, looking for genetic risk and protective factors and why some at-risk people stay healthy.
Miscellaneous
Highline Research Advisors Initiates on Titan Pharmaceuticals with a Buy Rating
Highline Research Advisors analyst Michael Higgins started coverage of Titan Pharmaceuticals with a buy rating and a $3.00 target. Titan's lead program, Probuphine, is a set of four buprenorphine implants for opioid addiction that met co-primary endpoints in four Phase 3 trials.
Miscellaneous
Mock Sword Fireworks Devices Recalled
Big Fireworks is recalling about 1,040 Big Sword handheld fountain devices after two reports of the fountain exploding during use. No injuries have been reported; buyers should stop using them and return them for a refund.
Miscellaneous
People with Type 2 Diabetes Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections
Medtronic reported OpT2mise results in The Lancet: people with insulin-requiring type 2 diabetes using MiniMed pumps cut A1C by 1.1 percent versus 0.4 percent with multiple daily injections, with no severe hypoglycemia and more than 20% less total daily insulin.
Miscellaneous
Federal judge approves consent decree with New York dietary supplement maker
A federal judge signed a consent decree for permanent injunction against Mira Health Products of Farmingdale, New York, and two executives. FDA had warned consumers off the firm's Purity First B-50 in 2013 after lab analysis found two unlisted anabolic steroids, methasterone and dimethazine.
Miscellaneous
Graco Recalls Car Seats Due to Harness Buckle Problem
Graco is recalling several car seat models whose harness buckle can stick in the latched position, making it hard to get a child out quickly. Owners can order a free replacement buckle, and NHTSA suggests using another seat until the repair arrives.
Miscellaneous
Lubrizol Introduces Pharmaceutical-Grade TPU Excipients
Lubrizol's LifeScience Polymers group will introduce its Pathway thermoplastic polyurethane excipients, aimed at implantable controlled-release drug delivery, at the Controlled Release Society meeting in Chicago, July 13-16, alongside its Carbopol polymer line.
Miscellaneous
News from CPSC: Public Calendar
The CPSC's weekly public calendar shows no Commission briefings or meetings for the week of July 7, 2014, and lists staff meetings with outside parties, future meetings and an addendum. Listed meetings are open to the public unless stated otherwise.
Miscellaneous
Porter-Cable Fixed-Base Production Routers, Snow Throwers Recalled
CPSC posted two recalls: about 100,000 Porter-Cable fixed-base production routers and router bases in the U.S. and 7,800 in Canada, whose base handles lack insulation and pose a shock hazard, and All Power America snow throwers over a fire hazard.
Miscellaneous
Medtronic Neurosurgery, Medtronic Duet External Drainage and Monitoring System - Patient Line Tubing May Disconnect and Lead to Injury
Medtronic recalled its Duet External Drainage and Monitoring System because the patient line tubing can separate from its connectors. The FDA's Class I notice says failure could cause air in the skull, infection or improper CSF drainage; no deaths have been reported.
Miscellaneous
Gene type confers 26% chance of early sign by age 6
In the NIH-funded TEDDY study of 6,403 newborns, more than a quarter of children carrying two copies of a high-risk gene variant developed celiac disease autoimmunity by age 5. Swedish participants had higher celiac rates than those in the U.S., Finland and Germany at equal genetic risk.
Miscellaneous
FDA Updates for Health Professionals: drug Information
FDA's roundup for health professionals flags a new Boxed Warning against using viscous lidocaine for teething pain, Bristol-Myers Squibb's recall of six Coumadin for Injection lots over particulate matter, and rare hypersensitivity reactions to OTC acne products.
Miscellaneous
Christopher Sforzo, M.D., Named a 'Top Doctor' in Hand Surgery
Castle Connolly named Christopher R. Sforzo, a board-certified orthopedic surgeon at Florida Orthopedic Specialists and Sports Medicine in Sarasota, a regional Top Doctor in orthopedic surgery. He is fellowship trained in hand and upper extremity surgery.
Miscellaneous
FDA Drug Safety Podcast: FDA recommends not using lidocaine to treat teething pain and requires new Boxed Warning
FDA warns that prescription oral viscous lidocaine 2 percent should not be used for teething pain in infants and young children, and is requiring a Boxed Warning. Overdose or accidental swallowing can cause seizures, brain injury and death; FDA reviewed 22 serious cases.
Miscellaneous
FDA Drug Safety Podcast: FDA warns of rare but serious hypersensitivity reactions with certain over-the-counter topical acne products
FDA warns that OTC topical acne products sold under brands including Proactiv, Neutrogena and Clean & Clear can rarely cause serious, potentially life-threatening allergic reactions. FDA says it cannot tell whether the active ingredients, inactive ingredients or both are responsible.
Miscellaneous
FDA Drug Safety Podcast: FDA review of cardiovascular risks for diabetics taking hypertension drug olmesartan not conclusive; label updates required
FDA finished its safety review and found no clear evidence that olmesartan raises cardiovascular risk in diabetic patients, so its use recommendations stay the same, though study information must be added to the labels. Patients should not stop blood pressure medicine without asking their doctor.
1542 stories